B+
Bull case
20%
Probability
Target price
$4.50
Analysis reference price unavailable
Analysis 2026-07-28 · RankAlpha Sentiment Codex
PLYX
Polaryx TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
The financing provides capital specifically intended to support SOTERIA, while the Phase 2 basket design and FDA safe-to-proceed status create a potentially meaningful re-rating path if initiation, enrollment, and early data are delivered on schedule. [#SEC-8K-2026-05-28] [#10-K-2026-03-24]
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Future equity financing could cause material dilution, particularly if conducted below the May financing price.
Momentum
98
Value
41
Sentiment
61
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.75 · Bull $4.50 · Bear $0.90Analysis 2026-07-28; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-28 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $7.50
Why
Momentum98 · Δ7d -
Value41 · Δ7d 0.0
Sentiment61 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • Future equity financing could cause material dilution, particularly if conducted below the May financing price.
- • Limited runway and substantial-doubt going-concern language create recurring financing risk.
- • The company has no approved products or near-term revenue, reported substantial doubt about continuing as a going concern, and estimated pre-financing cash coverage only through Q3 2026.
Catalyst clock
2026-09-30
Runway and dilution remain the near-term trading driver
Lead driver: Sentiment · See AI snapshot
Momentum
98
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
-5.2
Sentiment
61
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 98.3 / Value 41.2 / Sentiment 61.5
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-07-28. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$1.75
Analysis reference price unavailable
Analysis 2026-07-28 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$0.90
Analysis reference price unavailable
Analysis 2026-07-28 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$104.68M
Beta
-
Shares Out
49.85M
P/E (TTM) · Derived
-11.1
P/S (TTM)
-
P/FCF (TTM) · Derived
-17.17
Rev YoY
-
EPS YoY
+34.3%
Gross Margin
-
Op Margin
-
Net Debt
-$5.14M
Current Ratio
13.53
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data